Divisions of, Division of, Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
Division of, Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Dig Endosc. 2021 May;33(4):621-628. doi: 10.1111/den.13829. Epub 2020 Oct 7.
Preoperative colonoscopy is often incomplete for stenotic colorectal cancers (CRC). This prospective observational study aimed to evaluate the ability of an ultrathin colonoscope (UTC) to inspect the whole colon by passing through the stenotic CRC.
All patients who underwent preoperative colonoscopy for stenotic CRCs at Shizuoka Cancer Center were examined for eligibility. If a standard colonoscope (PCF-H290ZI) could not pass because of a stenosis, the patients were recruited. All of the eligible patients were prospectively enrolled when informed consent could be obtained, and complete colonoscopy was attempted again using an UTC (PCF-PQ260L). Patients with stent placement and those requiring right hemicolectomy were not recruited. Primary endpoints were pass-through and cecal intubation rates. The detected synchronous neoplasias (adenomas and cancers) and their pathological findings after resection were evaluated.
A total of 100 patients were enrolled between September 2017 and February 2019. The mean age was 65.6 ± 10.8 years, and 59% were male. The pass-through and cecal intubation rates were 67% (67/100) and 58% (58/100), respectively. Synchronous lesions located proximal to the stenoses were detected in 65.5% (38/58) of the complete colonoscopies, with a total of 86 lesions, including 18 advanced neoplasias with three invasive cancers.
When standard colonoscopy cannot pass through stenotic CRC, ultrathin colonoscopy can be considered as an option to inspect the whole colon proximal to the stenosis because treatment strategy can potentially be changed by detecting synchronous neoplasias proximal to the stenosis before surgery. (UMIN000028505).
术前结肠镜检查对于狭窄型结直肠癌(CRC)常不完整。本前瞻性观察性研究旨在评估超微结肠镜(UTC)通过狭窄型 CRC 检查整个结肠的能力。
所有在静冈癌症中心因狭窄型 CRC 行术前结肠镜检查的患者均进行资格检查。如果标准结肠镜(PCF-H290ZI)因狭窄而无法通过,则招募患者。当获得知情同意时,所有符合条件的患者均被前瞻性纳入,并使用 UTC(PCF-PQ260L)再次尝试进行完整结肠镜检查。未招募放置支架和需要右半结肠切除术的患者。主要终点是通过和盲肠插管率。评估切除后检测到的同步新生物(腺瘤和癌症)及其病理发现。
2017 年 9 月至 2019 年 2 月期间共纳入 100 例患者。患者平均年龄为 65.6±10.8 岁,59%为男性。通过和盲肠插管率分别为 67%(67/100)和 58%(58/100)。在 58 次完整结肠镜检查中,65.5%(38/58)检测到位于狭窄部位近端的同步病变,共有 86 个病变,包括 18 个高级别新生物,其中 3 个为浸润性癌症。
当标准结肠镜无法通过狭窄型 CRC 时,超微结肠镜可作为检查狭窄部位近端整个结肠的一种选择,因为在手术前检测到狭窄部位近端的同步新生物,可能会改变治疗策略。(UMIN000028505)。